These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21857923)

  • 1. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans.
    Yuan Y; Cao P; Smith MA; Kramp K; Huang Y; Hisamoto N; Matsumoto K; Hatzoglou M; Jin H; Feng Z
    PLoS One; 2011; 6(8):e22354. PubMed ID: 21857923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-OHDA-induced dopaminergic neurodegeneration in Caenorhabditis elegans is promoted by the engulfment pathway and inhibited by the transthyretin-related protein TTR-33.
    Offenburger SL; Ho XY; Tachie-Menson T; Coakley S; Hilliard MA; Gartner A
    PLoS Genet; 2018 Jan; 14(1):e1007125. PubMed ID: 29346382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.
    Chen CY; Weng YH; Chien KY; Lin KJ; Yeh TH; Cheng YP; Lu CS; Wang HL
    Cell Death Differ; 2012 Oct; 19(10):1623-33. PubMed ID: 22539006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a
    Naidoo D; de Lencastre A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
    Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
    Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Caenorhabditis elegans neuroligin-like glit-1, the apoptosis pathway and the calcium chaperone crt-1 increase dopaminergic neurodegeneration after 6-OHDA treatment.
    Offenburger SL; Jongsma E; Gartner A
    PLoS Genet; 2018 Jan; 14(1):e1007106. PubMed ID: 29346364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.
    Yao C; Johnson WM; Gao Y; Wang W; Zhang J; Deak M; Alessi DR; Zhu X; Mieyal JJ; Roder H; Wilson-Delfosse AL; Chen SG
    Hum Mol Genet; 2013 Jan; 22(2):328-44. PubMed ID: 23065705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
    Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
    Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.
    Liu Z; Hamamichi S; Lee BD; Yang D; Ray A; Caldwell GA; Caldwell KA; Dawson TM; Smith WW; Dawson VL
    Hum Mol Genet; 2011 Oct; 20(20):3933-42. PubMed ID: 21768216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in LRRK2 potentiate age-related impairment of autophagic flux.
    Saha S; Ash PE; Gowda V; Liu L; Shirihai O; Wolozin B
    Mol Neurodegener; 2015 Jul; 10():26. PubMed ID: 26159606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
    Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
    Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.
    Tsika E; Kannan M; Foo CS; Dikeman D; Glauser L; Gellhaar S; Galter D; Knott GW; Dawson TM; Dawson VL; Moore DJ
    Neurobiol Dis; 2014 Nov; 71():345-58. PubMed ID: 25174890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
    Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
    Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviating chronic ER stress by p38-Ire1-Xbp1 pathway and insulin-associated autophagy in C. elegans neurons.
    Guan L; Zhan Z; Yang Y; Miao Y; Huang X; Ding M
    PLoS Genet; 2020 Sep; 16(9):e1008704. PubMed ID: 32986702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Functional Assessment of LRRK2 in Caenorhabditis elegans Mechanosensory Neurons.
    Kuwahara T
    Methods Mol Biol; 2021; 2322():175-184. PubMed ID: 34043203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
    Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
    J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
    Niu J; Yu M; Wang C; Xu Z
    J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.
    Cresto N; Gardier C; Gaillard MC; Gubinelli F; Roost P; Molina D; Josephine C; Dufour N; Auregan G; Guillermier M; Bernier S; Jan C; Gipchtein P; Hantraye P; Chartier-Harlin MC; Bonvento G; Van Camp N; Taymans JM; Cambon K; Liot G; Bemelmans AP; Brouillet E
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models.
    Chittoor-Vinod VG; Villalobos-Cantor S; Roshak H; Shea K; Abalde-Atristain L; Martin I
    J Neurosci; 2020 Aug; 40(32):6234-6249. PubMed ID: 32605938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.